ArticleIndian journal of ophthalmology2021
The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
Article in Indian journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Mucormycosis of the Mandible and Tongue: A Systematic Scoping Review.International dental journal · 2024Article
- Prosthodontic Rehabilitation's Role in Alleviating Anxiety and Depression in Mucormycosis-Induced Maxillectomy Patients Post-COVID-19.Medical science monitor : international medical journal of experimental and clinical research · 2023Article
- Analysis of the Effectiveness of 3D Printed Patient-Specific Implants for Reconstruction of Maxillary Defect Secondary to Mucormycosis.Journal of maxillofacial and oral surgery · 2023Article
- A cross-sectional study to describe the spectrum of ocular manifestations and risk factors of mucormycosis presenting to a tertiary hospital of East India.Indian journal of ophthalmology · 2023Article
- Diabetes and COVID-19: Short- and Long-Term Consequences.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2022Review
- Article
- Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality.Disease models & mechanisms · 2022Article
- First Molecular Identification of Three Clinical Isolates of Fungi Causing Mucormycosis in Honduras.Infectious disease reports · 2022Article
- Resolving the equation between mucormycosis and COVID-19 disease.Molecular biology reports · 2022Review
- COVID-19 and Plethora of Fungal Infections.Current fungal infection reports · 2022Review
- How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?Mycopathologia · 2021Article
- COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.PLoS neglected tropical diseases · 2021Review
- Fungal Taxa Responsible for Mucormycosis/"Black Fungus" among COVID-19 Patients in India.Journal of fungi (Basel, Switzerland) · 2021Article
- Emergence of a medley of invasive fungal infections amidst the coronavirus disease 2019 (COVID-19) pandemic in India.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2021Article
- COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.American journal of otolaryngologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.